|1.||French, Samuel W: 10 articles (12/2014 - 04/2008)|
|2.||French, Barbara A: 9 articles (12/2014 - 04/2008)|
|3.||Li, Jun: 7 articles (12/2014 - 04/2008)|
|4.||Oliva, Joan: 6 articles (08/2010 - 04/2008)|
|5.||Bardag-Gorce, Fawzia: 6 articles (08/2010 - 04/2008)|
|6.||Omary, M Bishr: 5 articles (11/2013 - 09/2008)|
|7.||French, S W: 4 articles (08/2013 - 06/2011)|
|8.||Tillman, Brittany: 3 articles (12/2014 - 10/2014)|
|9.||Persano, Luca: 3 articles (07/2014 - 11/2010)|
|10.||French, B A: 3 articles (08/2013 - 06/2011)|
11/15/1999 - "The results for this series did not give any evidence that MDB improved the survival of the cancer patients. "
12/01/2011 - "The goal of this study was to analyze these survivin features in the pediatric MDB tumor samples and its impact on clinical outcome. "
04/01/2008 - "The present study provides evidence that links MDB formation induced by chronic drug injury, with preneoplasia and later to the formation of tumors, which develop long after drug withdrawal. "
07/01/1998 - "[Evaluation study of the opinions on the Di Bella multi-therapy (MDB) of tumor patients]."
01/01/2014 - "Histologically, 5-ALA-intense biopsies from inner areas were characterized by a significant amount of cancer cells, whereas 5-ALA faint regions from peripheral areas displayed normal cerebellar features, with MDB cells infiltrating healthy tissues. "
01/01/2009 - "This result confirms the efficacy of this biological multiple treatment (MDB); it is also in line with the positive results already published on the use of MDB in low-grade NHL (66) and in stage 3 or 4 lung carcinomas (53). "
12/01/2008 - "The achievement of objective results, without toxicity, in this case, proves the effectiveness of this therapy and confirms the positive results already published on the use of MDB for Low-Grade NHL, and pulmonary carcinomas in the 3rd and 4th stages. "
12/01/2008 - "DiBella's biological therapy (MDB), was found, after seven months, to have a 50% reduction in objective measures of her carcinoma and was totally cured after 14 months. "
|3.||Liver Diseases (Liver Disease)
10/01/2014 - "This data constitutes the first demonstration of the upregulation of the MyD88-dependent TLR4/NFκB pathway in AH and NASH where MDBs formed, via the NFκB-CXCR4/7 pathway, and provides further insight into the mechanism of MDB formation in human liver diseases. "
10/01/2014 - "However, little is known as to how TLR signaling is regulated in MDB formation during chronic liver disease development. "
09/01/2008 - "We hypothesized that genetic variables contribute to the extent of MDB formation, because not all patients with an MDB-associated liver disease develop inclusions. "
11/01/2015 - "These findings have demonstrated that the observation of MDB together with ubiquitin positivity will be helpful in the evaluation of the models of diagnosis, staging, and therapy in patients with chronic liver disease."
11/01/2013 - "Expression of the adenosine-generating enzyme, CD73, contributes to experimental MDB induction and is highly regulated in MDB-associated liver injury in mice and in chronic human liver disease."
|4.||Lung Neoplasms (Lung Cancer)
|9.||Keratin-8 (Keratin 8)
|10.||Risperidone (Risperdal Consta)
|3.||Drug Therapy (Chemotherapy)